- Home
- Automated
- List of product information
- CRAVIT OPHTHALMIC SOLUTION 0.5% W/V [SIN11826P]
CRAVIT OPHTHALMIC SOLUTION 0.5% W/V [SIN11826P]
Active ingredients: CRAVIT OPHTHALMIC SOLUTION 0.5% W/V
Product Info
CRAVIT OPHTHALMIC SOLUTION 0.5% W/V
[SIN11826P]
Product information
Active Ingredient and Strength | LEVOFLOXACIN HYDRATE - 0.5% W/V |
Dosage Form | SOLUTION |
Manufacturer and Country | SANTEN PHARMACEUTICAL CO., LTD (NOTO PLANT) - JAPAN |
Registration Number | SIN11826P |
Licence Holder | SANTEN PHARMACEUTICAL ASIA PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | S01AX19 |
[Indications]
The following infections caused by levofloxacin-susceptible strains of Staphylococcus sp., Streptococcus sp., Streptococcus pneumoniae, Micrococcus sp., Enterococcus sp., Corynebacterium sp., Pseudomonas sp., Pseudomonas aeruginosa, Haemophilus sp. (H. influenzae, H. aegyptius [Koch-Weeks bacillus]), Moraxella (Branhamella) catarrhalis, Moraxella sp. (Morax-Axenfeld bacillus), Serratia sp., Klebsiella sp., Proteus sp., Acinetobacter sp., Enterobacter sp,. Propionibacterium acnes :
Blepharitis, hordeolum, dacryocystitis, conjunctivitis, tarsadenitis, keratitis, corneal ulcer, and postoperative infections.
[Dosage and Administration]
Usually, instill 1 drop a time 3 times daily. The dosage may be adjusted according to the patient's symptoms.
[Contraindications] (Cravit ophthalmic solution is contraindicated in the following patients.)
Patients with a history of hypersensitivity to the ingredient of this product, Ofloxacin or any quinolone antibiotics.
